Immunogenicity of Metastatic Breast Cancer and Therapeutic Efficacy of Mutation-Reactive Autologous Tumor-Infiltrating Lymphocytes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes
J. Clin. Oncol 2022 Jun 01;40(16)1741-1754, N Zacharakis, LM Huq, SJ Seitter, SP Kim, JJ Gartner, S Sindiri, VK Hill, YF Li, BC Paria, S Ray, B Gasmi, CC Lee, TD Prickett, MR Parkhurst, PF Robbins, MM Langhan, TE Shelton, AY Parikh, ST Levi, JM Hernandez, CD Hoang, RM Sherry, JC Yang, SA Feldman, SL Goff, SA RosenbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.